Ascertaining Diagnosis Classification With Elicited Speech
ACES
1 other identifier
observational
255
1 country
1
Brief Summary
Cross-sectional observational study of the relationship between speech patterns and psychiatric symptoms and disorders.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2022
CompletedFirst Submitted
Initial submission to the registry
October 25, 2022
CompletedFirst Posted
Study publicly available on registry
November 1, 2022
CompletedNovember 1, 2022
October 1, 2022
1.9 years
October 25, 2022
October 29, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Speech features from the Winterlight Speech Assessment
Acoustic and linguistic measures of speech computed based on performance on the Winterlight Speech Assessment
Baseline
Secondary Outcomes (5)
Brief Symptom Inventory
Baseline
Patient Health Questionnaire - 9
Baseline
Generalized Anxiety Disorder - 7
Baseline
Prodromal Questionnaire - Brief
Baseline
Scale for the Assessment of Thought Language and Communication
Baseline
Study Arms (2)
Psychiatric patient group
Current diagnosis in the medical chart of any of the following. The patient may be in partial but not full remission. Comorbidity among these disorders and other unlisted disorders is expected and allowable. * Schizophrenia-spectrum disorder - schizophrenia, schizophreniform, schizoaffective disorder, delusional disorder, brief psychotic disorder, or unspecified psychotic disorder * Bipolar spectrum disorder - bipolar I or II disorder, cyclothymia, unspecified or other specified bipolar disorder * (Unipolar) Depressive disorder - major depressive disorder, dysthymia, unspecified and other specified depressive disorder * Anxiety disorder - obsessive-compulsive disorder, generalized anxiety disorder, panic disorder, post-traumatic stress disorder * Personality disorder - borderline personality disorder * Attention-Deficit Hyperactivity Disorder
Healthy controls
Healthy comparison subjects with no known psychiatric diagnosis
Interventions
Digital assessment of speech and language abilities
Eligibility Criteria
Patients whose treatment team believes they would be appropriate for a research study will be approached by research staff and the research project will be explained to them in detail. Inpatients will be approached during their admission and after initial stabilization. Outpatients will be approached before or after their scheduled appointments. Educational seminars regarding this study may be held to inform clinicians and staff of our goals and protocol. Potential participants will be made aware that declining participation will not affect their care. Informed consent will be obtained from all those interested in participating in the study.
You may qualify if:
- Speaks with conversational proficiency with conversational proficiency
- Current diagnosis in the medical chart of any of the following. The patient may be in partial but not full remission. Comorbidity among these disorders and other unlisted disorders is expected and allowable.
- Schizophrenia-spectrum disorder - schizophrenia, schizophreniform, schizoaffective disorder, delusional disorder, brief psychotic disorder, or unspecified psychotic disorder
- Bipolar spectrum disorder - bipolar I or II disorder, cyclothymia, unspecified or other specified bipolar disorder
- (Unipolar) Depressive disorder - major depressive disorder, dysthymia, unspecified and other specified depressive disorder
- Anxiety disorder - obsessive-compulsive disorder, generalized anxiety disorder, panic disorder, post-traumatic stress disorder
- Personality disorder - borderline personality disorder
- Attention-Deficit Hyperactivity Disorder
- Healthy comparison subjects
- Age 14 - 50 years
- Has capacity and willing to sign informed consent; if minor, parent is willing to give consent and child is willing to give assent.
- Screening will not include a pregnancy test. Pregnant women will not be screened out of the study because the study procedures are of very low risk overall, and pregnancy does not place the participant or the fetus at any significant risk.
- Minors will be included in the study because diagnostic ambiguity is prevalent before the age of 18 and this patient group is particularly in need of accurate prognosis and treatment. Therefore, it is of vital importance that the conclusions of the study be applicable to minors and that they be included among the participants.
You may not qualify if:
- Participants with substance-induced disorders or disorders secondary to a general medical condition will not be included as underlying brain changes may be different from "primary" psychiatric disorders.
- Disorders affecting speech or language, such as aphasia, intellectual disability (IQ\<70), or language disorder, or movement disorders affecting speech like tardive dyskinesia, or physical impairments causing significant distortions to speech
- Serious neurological or endocrine disorder or any medical condition or treatment known to affect the brain and/or language, including but not limited to: neurodegenerative disorders, traumatic brain injury with active symptoms, autism spectrum disorder, encephalitis, epilepsy
- Cognitive or language limitations, or any other factor that would preclude subjects providing informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Northwell Healthlead
- Winterlight Labscollaborator
Study Sites (1)
Zucker Hillside Hospital
Glen Oaks, New York, 11004, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sunny X Tang, MD
Northwell Health, The Feinstein Institutes of Medical Research
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
October 25, 2022
First Posted
November 1, 2022
Study Start
October 1, 2020
Primary Completion
September 1, 2022
Study Completion
September 1, 2022
Last Updated
November 1, 2022
Record last verified: 2022-10
Data Sharing
- IPD Sharing
- Will not share